PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15086213-0	2004	Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis.	Octreotide	10-20	interleukin 6	Homo sapiens	45-58	
15086213-0	2004	Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis.	Octreotide	10-20	interleukin 6	Homo sapiens	60-64	
15086213-1	2004	BACKGROUND/AIMS: Based on former studies in experimental animals on the effect of octreotide on serum and ascitic levels of tumor necrosis factor-alpha and interleukin-6 in the field of necrotizing pancreatitis, the present study was designed to investigate the effect of octreotide on serum interleukin-6 of patients with acute edematous pancreatitis.	Octreotide	82-92	interleukin 6	Homo sapiens	156-169	
15086213-1	2004	BACKGROUND/AIMS: Based on former studies in experimental animals on the effect of octreotide on serum and ascitic levels of tumor necrosis factor-alpha and interleukin-6 in the field of necrotizing pancreatitis, the present study was designed to investigate the effect of octreotide on serum interleukin-6 of patients with acute edematous pancreatitis.	Octreotide	82-92	interleukin 6	Homo sapiens	292-305	
15086213-5	2004	RESULTS: Mean concentrations of interleukin-6 of patients treated with octreotide 200 microg tid were 59.52 pg/mL before and 94.08, 46.25, 49.94, 58.16 and 26.08 pg/mL at 3, 6, 24, 48 and 72 hours after the start of therapy respectively.	Octreotide	71-81	interleukin 6	Homo sapiens	32-45	
15086213-9	2004	CONCLUSIONS: A transient, but not statistically significant, decrease of serum interleukin-6 levels was documented after administration of octreotide in the field of acute edematous pancreatitis.	Octreotide	139-149	interleukin 6	Homo sapiens	79-92